Associations of symptoms of anxiety and depression with diabetes and cardiovascular risk factors in older people with intellectual disability

By  

JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, Vol. 59, Iss. 2, 2015-02 ,pp. : 176-185

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diabetes and cardiovascular disease: time for individualized risk reduction

By McFarlane Samy I   Sowers James R  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 451-453

Future Medicine

Access to resources Recommend Favorite

Prevalence and risk factors of obesity, hypertension, dyslipidemia and diabetes mellitus before and after adult living donor liver transplantation

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 7, 2015-07 ,pp. : 764-770

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapy

By Charland Scott L.   Malone Daniel C.  

Current Medical Research and Opinion, Vol. 26, Iss. 2, 2010-02 ,pp. : 365-375

Informa Healthcare

Access to resources Recommend Favorite

Evolving Role of Non‐Statin Therapy for the Management of Dyslipidemia and Cardiovascular Risk Reduction: Past, Present, and Future

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 38, Iss. 2, 2018-02 ,pp. : 164-171

John Wiley & Sons Inc

Access to resources Recommend Favorite